Clinical Trials Browser

Phase 1/2 × Focal Cortical Dysplasia × 90 days × Clear all

NCT06392009 2026-04-01

Astroscape: A Study of Radiprodil on Safety, Tolerability, Pharmacokinetics, and Effect on Seizures and Behavioral Symptoms in Patients With TSC or FCD Type II

Phase 1/2 Active not recruiting

Focal Cortical Dysplasia, Tuberous Sclerosis